Investor
The company currently has 11 locations delivering virtual-supported care, but now plans to open "several" more in the first half of 2021.
This merger comes over a year after news broke that Outcome Health faced a number of legal battles.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.
The deal is expected to close in the second quarter of 2021. It will value the combined company at approximately $1.1 billion.
Also: Valo Health closes $300 million for machine learning drug discovery; Blue Note Therapeutics supports its in-development prescription DTx with $26.25 million.
The digital MSK company is looking to bundle the non-invasive, non-addictive pain reduction device alongside the rest of its employer-focused offerings.
According to Business Insider, the pair made a $70 million licensing deal.
Also: Mantra Health appoints medical director; Deep 6 AI creates VP of life sciences role.
Investment firm Kuwait Life Sciences Company's Dr. Mussaad M. Al-Razouki gives a breakdown of recently filed or finalized digital health SPACs, as well as a list of unicorns ripe for a potential merger.